Magnaldehyde BCAS# 92829-72-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 92829-72-6 | SDF | Download SDF |
| PubChem ID | 5320888 | Appearance | Powder |
| Formula | C18H16O3 | M.Wt | 280.3 |
| Type of Compound | Lignans | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (E)-3-[4-hydroxy-3-(2-hydroxy-5-prop-2-enylphenyl)phenyl]prop-2-enal | ||
| SMILES | C=CCC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)C=CC=O)O | ||
| Standard InChIKey | CWLSQIXOLLQBDC-HWKANZROSA-N | ||
| Standard InChI | InChI=1S/C18H16O3/c1-2-4-13-6-8-17(20)15(11-13)16-12-14(5-3-10-19)7-9-18(16)21/h2-3,5-12,20-21H,1,4H2/b5-3+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Magnaldehyde B is a natural lipase inhibitor(IC50= 96.96 uM). 2. Magnaldehyde B can inhibit the proliferation of tumor cells, and might be an anti-tumoric agent. |
Magnaldehyde B Dilution Calculator
Magnaldehyde B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.5676 mL | 17.838 mL | 35.6761 mL | 71.3521 mL | 89.1902 mL |
| 5 mM | 0.7135 mL | 3.5676 mL | 7.1352 mL | 14.2704 mL | 17.838 mL |
| 10 mM | 0.3568 mL | 1.7838 mL | 3.5676 mL | 7.1352 mL | 8.919 mL |
| 50 mM | 0.0714 mL | 0.3568 mL | 0.7135 mL | 1.427 mL | 1.7838 mL |
| 100 mM | 0.0357 mL | 0.1784 mL | 0.3568 mL | 0.7135 mL | 0.8919 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lappaol C
Catalog No.:BCN8676
CAS No.:64855-00-1
- 13-Methylberberine
Catalog No.:BCN8675
CAS No.:54260-72-9
- Aurantio-obtusin beta-D-glucoside
Catalog No.:BCN8674
CAS No.:129025-96-3
- Pomiferin
Catalog No.:BCN8673
CAS No.:572-03-2
- Resveratroloside
Catalog No.:BCN8672
CAS No.:38963-95-0
- Epimagnolin B
Catalog No.:BCN8671
CAS No.:1134188-26-3
- Moscatin
Catalog No.:BCN8670
CAS No.:108335-06-4
- Ophiopogonanone B
Catalog No.:BCN8669
CAS No.:1316759-83-7
- 4''-methyloxy-Genistin
Catalog No.:BCN8668
CAS No.:950910-16-4
- 4''-methyloxy-Daidzin
Catalog No.:BCN8667
CAS No.:1195968-02-5
- Lappaol F
Catalog No.:BCN8665
CAS No.:69394-17-8
- Parvisoflavanone
Catalog No.:BCN8664
CAS No.:49776-79-6
- Flemiphilippinin A
Catalog No.:BCN8678
CAS No.:140366-64-9
- Kudinoside D
Catalog No.:BCN8679
CAS No.:173792-61-5
- Perisesaccharide C
Catalog No.:BCN8680
CAS No.:1311473-28-5
- Cafestol
Catalog No.:BCN8681
CAS No.:469-83-0
- Huzhangoside B
Catalog No.:BCN8682
CAS No.:94795-70-7
- Protohypericin
Catalog No.:BCN8683
CAS No.:548-03-8
- Glabrol
Catalog No.:BCN8684
CAS No.:59870-65-4
- Isolindleyin
Catalog No.:BCN8685
CAS No.:87075-18-1
- Isopropyl ferulate
Catalog No.:BCN8686
CAS No.:59831-94-6
- Licochalcone D
Catalog No.:BCN8687
CAS No.:144506-15-0
- Licochalcone E
Catalog No.:BCN8688
CAS No.:864232-34-8
- Conicasterol
Catalog No.:BCN8689
CAS No.:76758-18-4
Fabrication of enzyme-immobilized halloysite nanotubes for affinity enrichment of lipase inhibitors from complex mixtures.[Pubmed:25798866]
J Chromatogr A. 2015 May 1;1392:20-7.
Lipase is the key enzyme for catalyzing triglyceride hydrolysis in vivo, and lipase inhibitors have been used in the management of obesity. We present the first report on the use of lipase-adsorbed halloysite nanotubes as an efficient medium for the selective enrichment of lipase inhibitors from natural products. A simple and rapid approach was proposed to fabricate lipase-adsorbed nanotubes through electrostatic interaction. Results showed that more than 85% lipase was adsorbed into nanotubes in 90 min, and approximately 80% of the catalytic activity was maintained compared with free lipase. The specificity and reproducibility of the proposed approach were validated by screening a known lipase inhibitor (i.e., orlistat) from a mixture that contains active and inactive compounds. Moreover, we applied this approach with high performance liquid chromatography-mass spectrometry technique to screen lipase inhibitors from the Magnoliae cortex extract, a medicinal plant used for treating obesity. Two novel biphenyl-type natural lipase inhibitors magnotriol A and Magnaldehyde B were identified, and their IC50 values were determined as 213.03 and 96.96 muM, respectively. The ligand-enzyme interactions of Magnaldehyde B were further investigated by molecular docking. Our findings proved that enzyme-adsorbed nanotube could be used as a feasible and selective affinity medium for the rapid screening of enzyme inhibitors from complex mixtures.
Apoptosis-inducing and antitumor activity of neolignans isolated from Magnolia officinalis in HeLa cancer cells.[Pubmed:23192855]
Phytother Res. 2013 Sep;27(9):1419-22.
Two neolignans, 4'-methoxymagndialdehyde (1) and Magnaldehyde B (2), were isolated from the stem bark of Magnolia officinalis (Magnoliaceae), evaluated for apoptosis-inducing effects in human cervical epitheloid carcinoma HeLa cells. The apoptosis-inducing activity of compounds 1 and 2 were assessed by DNA content using flow cytometric analysis. In the immunoblotting analysis, the treatment with 1 and 2 resulted in the cleavage of procaspase-8 and -3 and poly(ADP-ribose)polymerase into active forms. In addition, in vivo, the administration of 2 to Lewis lung carcinoma-inoculated mice evidenced a significant inhibition of tumor growth (volume) with reduction of 28.7% at concentration of 20 mg/kg, as compared with the control mice. These findings suggest that 2 can inhibit the proliferation of tumor cells, and might be an anti-tumoric agent.
